381 related articles for article (PubMed ID: 22385471)
41. Design of iron chelators with therapeutic application.
Zhou T; Ma Y; Kong X; Hider RC
Dalton Trans; 2012 Jun; 41(21):6371-89. PubMed ID: 22391807
[TBL] [Abstract][Full Text] [Related]
42. Diagnosis and management of genetic haemochromatosis.
Dooley JS
Best Pract Res Clin Haematol; 2002 Jun; 15(2):277-93. PubMed ID: 12401308
[TBL] [Abstract][Full Text] [Related]
43. [Disturbed iron balance in hemochromatosis and inflammation. Discovery of iron-regulating hormone hepcidin gives new explanations].
Stål P; Gåfvels M; Eggertsen G; Holmström P
Lakartidningen; 2007 May 30-Jun 3; 104(22):1696-700. PubMed ID: 17601319
[No Abstract] [Full Text] [Related]
44. Clinical management of iron overload.
Tung BY; Kowdley KV
Gastroenterol Clin North Am; 1998 Sep; 27(3):637-54. PubMed ID: 9891701
[TBL] [Abstract][Full Text] [Related]
45. Hereditary haemochromatosis: detection and management.
Vautier G; Murray M; Olynyk JK
Med J Aust; 2001 Oct; 175(8):418-21. PubMed ID: 11700835
[TBL] [Abstract][Full Text] [Related]
46. [Erythrocytapheresis for hereditary haemochromatosis].
Rombout-Sestrienkova E; van Deursen CT; Janssen MC; van Kraaij MG; de Leeuw PW; Koek GH
Ned Tijdschr Geneeskd; 2012; 156(26):A4745. PubMed ID: 22759710
[TBL] [Abstract][Full Text] [Related]
47. Optimal management strategies for chronic iron overload.
Barton JC
Drugs; 2007; 67(5):685-700. PubMed ID: 17385941
[TBL] [Abstract][Full Text] [Related]
48. Hemochromatosis: pathophysiology, evaluation, and management of hepatic iron overload with a focus on MRI.
Golfeyz S; Lewis S; Weisberg IS
Expert Rev Gastroenterol Hepatol; 2018 Aug; 12(8):767-778. PubMed ID: 29966105
[TBL] [Abstract][Full Text] [Related]
49. Haemochromatosis: a clinical update for the practising physician.
Radford-Smith DE; Powell EE; Powell LW
Intern Med J; 2018 May; 48(5):509-516. PubMed ID: 29722188
[TBL] [Abstract][Full Text] [Related]
50. Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis.
Sikorska K; Bernat A; Wroblewska A
Hepatobiliary Pancreat Dis Int; 2016 Oct; 15(5):461-479. PubMed ID: 27733315
[TBL] [Abstract][Full Text] [Related]
51. Haemochromatosis.
Adams PC; Jeffrey G; Ryan J
Lancet; 2023 May; 401(10390):1811-1821. PubMed ID: 37121243
[TBL] [Abstract][Full Text] [Related]
52. Polycystic ovary syndrome and iron overload: biochemical link and underlying mechanisms with potential novel therapeutic avenues.
Mathew M; Sivaprakasam S; Phy JL; Bhutia YD; Ganapathy V
Biosci Rep; 2023 Jan; 43(1):. PubMed ID: 36408981
[TBL] [Abstract][Full Text] [Related]
53. New pharmacological concepts for the treatment of iron overload disorders.
Mair SM; Weiss G
Curr Med Chem; 2009; 16(5):576-90. PubMed ID: 19199923
[TBL] [Abstract][Full Text] [Related]
54. Genetic haemochromatosis: diagnosis and treatment of an iron overload disorder.
Johnson M; Mortimore G
Nurs Stand; 2022 Nov; 37(11):77-82. PubMed ID: 36124694
[TBL] [Abstract][Full Text] [Related]
55. Hemochromatosis-induced bipolar disorder: a case report.
Serata D; Del Casale A; Rapinesi C; Mancinelli I; Pompili P; Kotzalidis GD; Aimati L; Savoja V; Sani G; Simmaco M; Tatarelli R; Girardi P
Gen Hosp Psychiatry; 2012; 34(1):101.e1-3. PubMed ID: 21749841
[TBL] [Abstract][Full Text] [Related]
56. Iron in Health and Disease: An Update.
Lal A
Indian J Pediatr; 2020 Jan; 87(1):58-65. PubMed ID: 31520313
[TBL] [Abstract][Full Text] [Related]
57. Increased insulin secretory capacity but decreased insulin sensitivity after correction of iron overload by phlebotomy in hereditary haemochromatosis.
Abraham D; Rogers J; Gault P; Kushner JP; McClain DA
Diabetologia; 2006 Nov; 49(11):2546-51. PubMed ID: 17019598
[TBL] [Abstract][Full Text] [Related]
58. Cardiac involvement in hemochromatosis.
Gulati V; Harikrishnan P; Palaniswamy C; Aronow WS; Jain D; Frishman WH
Cardiol Rev; 2014; 22(2):56-68. PubMed ID: 24503941
[TBL] [Abstract][Full Text] [Related]
59. Iron effects versus metabolic alterations in hereditary hemochromatosis driven bone loss.
Baschant U; Altamura S; Steele-Perkins P; Muckenthaler MU; Spasić MV; Hofbauer LC; Steinbicker AU; Rauner M
Trends Endocrinol Metab; 2022 Sep; 33(9):652-663. PubMed ID: 35871125
[TBL] [Abstract][Full Text] [Related]
60. Iron overload and hematologic malignancies.
Franchini M; Veneri D
Hematol J; 2004; 5(5):381-3. PubMed ID: 15448663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
